Major limitations, before their large-scale clinical application, are still represented by: (i) appropriate quality control for CNS biocompatibility and safety, including their complete, efficient and fast clearance/reabsorption, (ii) establishment of the ideal mechanism of NP-mediated drug delivery into the brain, and (iii) a careful consideration of the multiple factors that may affect NP efficacy into the brain microenvironment, such as the ideal material, size and shape, surface modification
Growth hormone releasing peptides increase IGF-1 levels, which directly supports Sertoli cell function and sperm development
If you are pregnant, breastfeeding, taking any medication or under medical supervision, please consult a doctor before use
The secondary evaluation outcomes were alterations in blood urea nitrogen (BUN), uric acid (UA), estimated glomerular filtration rate (eGFR), urinary AKI biomarkers, renal fibrosis biomarkers (transforming growth factor- 1 (TGF- 1 ), connective tissue growth factor (CTGF)), and traditional Chinese medicine (TCM) symptoms
